Our study measured α-synuclein-positive EV levels in platelet-poor plasma of PD patients and determined differences between PD patients, age-matched CU individuals, and patients with other neurodegenerative diseases, including AD dementia and DLB. This evidence concerns the gene SNCA and neurodegenerative disease.